Proposed issue of securities Announcement Summary Entity name ALTERITY THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Wednesday

Announcement Summary

ALTERITY THERAPEUTICS LIMITED

Date of this announcement

Wednesday February 10, 2021

The Proposed issue is:

placement or other type of issue

Total number of +securities proposed to be issued for a placement

or other type of issue

Proposed +issue date

Thursday February 11, 2021

Refer to next page for full details of the announcement

Part 1 - Entity and announcement details

ALTERITY THERAPEUTICS LIMITED

We (the entity named above) give ASX the following information

about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred

settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.

Date of this announcement

Wednesday February 10, 2021

The Proposed issue is:

placement or other type of issue

Part 7 - Details of proposed placement or other issue

Part 7A - Conditions

7A.1 - Are any of the following approvals required for the

placement or other type of issue?

Part 7B - Issue details

Details of +securities proposed to be issued

ASX +security code and description

ATH: ORDINARY FULLY PAID

Number of +securities proposed to be issued

Are the +securities proposed to be issued being issued for

a cash consideration?

Will these +securities rank equally in all respects from

their issue date with the existing issued +securities in that class?

7C.1 Proposed +issue date

Thursday February 11, 2021

Part 7D - Listing Rule requirements

7D.1 Has the entity obtained, or is it obtaining, +security

holder approval for the entire issue under listing rule 7.1?

7D.1b Are any of the +securities proposed to be issued without

+security holder approval using the entity's 15% placement capacity under listing rule 7.1?

7D.1b ( i ) How many +securities are proposed to be

issued without security holder approval using the entity's 15% placement capacity under listing rule 7.1?

7D.1c Are any of the +securities proposed to be issued without

+security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)?

7D.2 Is a party referred to in listing rule 10.11 participating

in the proposed issue?

7D.3 Will any of the +securities to be issued be +restricted

securities for the purposes of the listing rules?

7D.4 Will any of the +securities to be issued be subject

to +voluntary escrow?

Part 7E - Fees and expenses

7E.1 Will there be a lead manager or broker to the proposed

7E.2 Is the proposed issue to be underwritten?

7E.4 Details of any other material fees or costs to be incurred

by the entity in connection with the proposed issue

Part 7F - Further Information

7F.01 The purpose(s) for which the entity is issuing the

To further research and development activities and provide on-going

7F.1 Will the entity be changing its dividend/distribution

policy if the proposed issue proceeds?

7F.2 Any other information the entity wishes to provide about